NCT02502890View on ClinicalTrials.gov

Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy

CompletedOBSERVATIONAL
Enrollment

208

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Asthma
Trial Locations (9)

10032

Columbia University Medical Center, New York

20010

Children's National Medical Center, Washington D.C.

45229

Cincinnati Children's Hospital, Cincinnati

48202

Henry Ford Health System, Detroit

60611

Ann and Robert Lurie Children's Hospital of Chicago, Chicago

63110

St. Louis Children's Hospital, St Louis

75390

University of Texas Southwestern Medical Center, Dallas

80045

Children's Hospital Colorado, Aurora

02118

Boston University School of Medicine, Boston

All Listed Sponsors
collaborator

Inner-City Asthma Consortium

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02502890 - Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy | Biotech Hunter | Biotech Hunter